ADDISON, Ill., March 24, 2025 /PRNewswire/ -- Huntleigh Healthcare is proud to announce that the world-renowned Dawes-Redman CTG Analysis™ has been approved for use in the U.S. by the Food and Drug ...

CTG's revenue decreased by 4.9% year-over-year to $71.3 million in Q3 2023. Gross margin improved significantly by 300 basis points from the prior year to 27.3%. The company reported a net loss of ...

ADDISON, Ill., March 24, 2025 /PRNewswire/ -- Huntleigh Healthcare is proud to announce that the world-renowned Dawes-Redman CTG Analysis TM has been approved for use in the U.S. by the Food and Drug ...